Literature DB >> 8295422

Prenatal detection of Canavan disease by measurement of N-acetyl-L-aspartate in amniotic fluid.

R I Kelley1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8295422     DOI： 10.1007/BF00714302

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN： 0141-8955            Impact factor:   4.982


× No keyword cloud information.
  3 in total

1.  Prenatal diagnosis of Canavan disease.

Authors:  R Matalon; K Michals; P Gashkoff; R Kaul
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

2.  Prenatal diagnosis of Canavan disease.

Authors:  C Jakobs; H J ten Brink; P Divry; M O Rolland
Journal:  Eur J Pediatr       Date:  1992-08       Impact factor: 3.183

3.  Quantification of N-acetyl-L-aspartic acid in urine by isotope dilution gas chromatography-mass spectrometry.

Authors:  R I Kelley; J N Stamas
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982
  3 in total
  4 in total

1.  Prenatal diagnosis of Canavan disease--problems and dilemmas.

Authors:  G T Besley; O N Elpeleg; A Shaag; N J Manning; C Jakobs; J H Walter
Journal:  J Inherit Metab Dis       Date:  1999-05       Impact factor: 4.982

Review 2.  Biochemistry and molecular biology of Canavan disease.

Authors:  R Matalon; K Michals-Matalon
Journal:  Neurochem Res       Date:  1999-04       Impact factor: 3.996

3.  Prenatal diagnosis for Canavan disease: the use of DNA markers.

Authors:  R Matalon; R Kaul; G P Gao; K Michals; R G Gray; S Bennett-Briton; A Norman; M Smith; C Jakobs
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

Review 4.  Canavan disease. Analysis of the nature of the metabolic lesions responsible for development of the observed clinical symptoms.

Authors:  M H Baslow; T R Resnik
Journal:  J Mol Neurosci       Date:  1997-10       Impact factor: 3.444
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.